Pulling SEC filings + quote and writing the call…
LataMed AI Corp.
Next earnings ≈ Oct 20, 2026 · est. from filing cadence
High return on equity (32.9%).
Revenue (FY2025) $0.00 · FY2025
LataMed AI Corp. shows $0.00 in FY2025 revenue, and 32.9% ROE.
| Line item | FY23 | FY24 | FY25 |
|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 |
| Gross profit | — | — | — |
| Operating income | -$829K | -$3.30M | -$172K |
| Net income | -$1.73M | -$3.26M | -$207K |
| Diluted EPS | -$0.02 | -$0.11 | — |
| Net margin | — | — | — |
Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.
Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.
Sources: SEC EDGAR (CIK 0001477960, latest 10-Q filed 2026-05-20) · as of 6/22/2026, 9:51:35 PM.
Research and education only — not financial advice. EDGAR is not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities EDGAR rates; see Disclosures. Past performance does not guarantee future results. Do your own research.
1043 tracked peers · median